Summary: Creative Biolabs offers single domain antibody Discovery Service for Blood-brain Barrier Proteins. Our technology also aims to target endogenous transport systems, including carrier-mediated transporters such as glucose and amino acid carriers, receptor-mediated transcytosis for insulin, transferrin or low-density lipoproteins (LRP1) and the active efflux transporters such as p-glycoprotein. https://www.creative-biolabs.com/Anti-BBB-Nanobody-Discovery-Service.html
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
